Compounds > daunorubicin
Page last updated: 2024-08-23

daunorubicin and tetramethylrhodamine

daunorubicin has been researched along with tetramethylrhodamine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eytan, GD; Katzir, H; Regev, R; Yeheskely-Hayon, D1
Cannon, RD; Gillet, JP; Gottesman, MM; Holmes, AR; Keniya, MV; Lamping, E; Niimi, M1

Other Studies

2 other study(ies) available for daunorubicin and tetramethylrhodamine

ArticleYear
Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
    The FEBS journal, 2007, Volume: 274, Issue:23

    Topics: Acceleration; Anesthetics; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Calcium Channel Blockers; Cell Membrane; Cell Membrane Permeability; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Excipients; Fluorescence Polarization; Fluorescent Dyes; Humans; K562 Cells; Membrane Fluidity; Rhodamines; Surface-Active Agents; Verapamil

2007
Drug resistance is conferred on the model yeast Saccharomyces cerevisiae by expression of full-length melanoma-associated human ATP-binding cassette transporter ABCB5.
    Molecular pharmaceutics, 2014, Oct-06, Volume: 11, Issue:10

    Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clorgyline; Daunorubicin; Humans; Melanoma; Rhodamine 123; Rhodamines; Saccharomyces cerevisiae; Tacrolimus

2014